MCID: HYP026
MIFTS: 39

Hypoglycemic Coma malady

Categories: Endocrine diseases, Neuronal diseases

Aliases & Classifications for Hypoglycemic Coma

About this section

Summaries for Hypoglycemic Coma

About this section
MalaCards based summary: Hypoglycemic Coma is related to acyl-coa dehydrogenase, medium chain, deficiency of and hepatopulmonary syndrome. An important gene associated with Hypoglycemic Coma is INS (Insulin), and among its related pathways are Cardiac Progenitor Differentiation and Differentiation Pathway. Affiliated tissues include brain, liver and temporal lobe, and related mouse phenotypes are muscle and nervous system.

Related Diseases for Hypoglycemic Coma

About this section

Diseases related to Hypoglycemic Coma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 52)
idRelated DiseaseScoreTop Affiliating Genes
1acyl-coa dehydrogenase, medium chain, deficiency of11.0
2hepatopulmonary syndrome10.2INS, VEGFA
3cerebritis10.1
4neutral lipid storage disease with myopathy10.1IGF2, INS
5maturity-onset diabetes of the young, type 1310.1IGF2, INS
6keloids10.1IGF2, INS
7rapp-hodgkin syndrome10.1IGF2, INS
8paroxysmal nonkinesigenic dyskinesia 210.1HBA2, INS
9fetal warfarin syndrome10.1IGF2, INS
10pleuropulmonary blastoma10.1HBA2, INS
11tmem231-related joubert syndrome10.1HBA2, INS
12papillary craniopharyngioma10.1INS, VEGFA
13diabetic cataract10.1IGF2, INS
14diabetes mellitus, insulin-dependent, 810.1HBA2, INS
15anorexia nervosa10.1
16gerstmann syndrome10.1IGF2, INS
17hemopericardium10.1HBA2, INS
18neurogenic arthropathy10.0IGF2, INS
19spondylolysis10.0INS, VEGFA
20chondroma10.0IGF2, INS
21mucopolysaccharidosis10.0NTF3, VEGFA
22insulin autoimmune syndrome10.0
23rumination disorder10.0INS, NTF3
24citrullinemia, type ii, neonatal-onset10.0INS, VEGFA
25thrombophilia10.0IGF2, INS
26submucous uterine fibroid9.9HBA2, INS, VEGFA
27hypersensitivity syndrome, carbamazepine-induced9.9HBA2, INS, VEGFA
28vernal conjunctivitis9.9HBA2, INS, VEGFA
29fissured tongue9.9INS, NTF3
30hepatocellular carcinoma9.9
31hepatitis9.9
32hypoglycemia9.9
33dilated cardiomyopathy9.8INS, NTF3, VEGFA
34schizophrenia9.8
35myocardial infarction9.8
36cerebral hemorrhage9.8
37hepatitis b9.8
38hydrocephalus9.8
39insulinoma9.8
40normal pressure hydrocephalus9.8
41ischemia9.8
42benign pleural mesothelioma9.8
43silent myocardial infarction9.8
44central pontine myelinolysis9.8
45neuronitis9.8
46peritonitis9.8
47acth deficiency9.8
48phyllode tumor9.8
49endotheliitis9.8
50brucella canis brucellosis9.7HBA2, IGF2, INS, VEGFA

Comorbidity relations with Hypoglycemic Coma via Phenotypic Disease Network (PDN):

(show all 23)
Active Peptic Ulcer DiseaseAcute Cystitis
Acute Kidney FailureBronchitis
Chronic Kidney FailureChronic Myocardial Ischemia
Decubitus UlcerDeficiency Anemia
Diabetic PolyneuropathyFamilial Atrial Fibrillation
Heart DiseaseHypertension, Essential
HypoglycemiaIron Deficiency Anemia
Ischemic Heart DiseaseKidney Disease
Microvascular Complications of Diabetes 1Peripheral Vascular Disease
Protein-Energy MalnutritionRespiratory Failure
Schizophreniform DisorderTransient Cerebral Ischemia
Hypothyroidism

Graphical network of the top 20 diseases related to Hypoglycemic Coma:



Diseases related to hypoglycemic coma

Symptoms & Phenotypes for Hypoglycemic Coma

About this section

MGI Mouse Phenotypes related to Hypoglycemic Coma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.1IGF2, INS, NTF3, VEGFA
2MP:00036318.5IGF2, INS, NTF3, SETDB1, VEGFA
3MP:00053898.4HBA2, IGF2, INS, NTF3, VEGFA
4MP:00053918.3IGF2, INS, NTF3, VEGFA
5MP:00107687.9HBA2, IGF2, INS, NTF3, SETDB1, VEGFA

Drugs & Therapeutics for Hypoglycemic Coma

About this section

Drugs for Hypoglycemic Coma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Etanerceptapproved, investigationalPhase 1, Phase 2403185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
2
EverolimusapprovedPhase 1, Phase 21940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
3
Exenatideapproved, investigationalPhase 1, Phase 2296141758-74-915991534
Synonyms:
141732-76-5
141758-74-9
286014-72-0
335149-21-8
AC 2993
AC 2993 LAR
AC 2993A
AC-2993
AC002993
AC2993
AC2993a
Bydureon
Byetta
 
C074031
CHEBI:490990
CHEMBL414357
Ex4 peptide
Exenatide
Exenatide Synthetic
Exenatide synthetic
Exendin 4
Exendin 4 (Heloderma suspectum)
Exendin-4
Extendin-4
LY2148568
Synthetic exendin-4
UNII-9P1872D4OL
4
Sirolimusapproved, investigationalPhase 1, Phase 2194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
5
Daclizumabapproved, investigationalPhase 1, Phase 298152923-56-3
Synonyms:
 
Dacliximab
Daclizumab beta
6
Tacrolimusapproved, investigationalPhase 1, Phase 21102104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
7
Insulin AspartapprovedPhase 2442116094-23-616132418
Synonyms:
(AspB28)-human insulin
1024611-56-0
116094-23-6
139532-40-4
28(sup B)-L-Aspartic acid-insulin (human)
877034-90-7
AspB28-insulin (human)
Aspart
Aspart Insulin
Aspart insulin
B28-Asp-insulin
B28-Aspart-Insulin
INA-X 14
 
INA-X14
Insulin X14
Insulin aspart
Insulin aspart [USAN]
Insulin aspart protamine recombinant
Insulin aspart recombinant
Insulin, Asp(B28)
LS-185932
NovoLog
NovoMix 30
NovoRapid
NovoRapid 30 Mix
Novolog mix 70/30
UNII-D933668QVX
8
ZincapprovedPhase 222967440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
9AnalgesicsPhase 1, Phase 211733
10IncretinsPhase 1, Phase 21579
11Peripheral Nervous System AgentsPhase 1, Phase 223689
12Hypoglycemic AgentsPhase 1, Phase 25896
13Immunosuppressive AgentsPhase 1, Phase 213086
14Analgesics, Non-NarcoticPhase 1, Phase 26501
15Anti-Inflammatory AgentsPhase 1, Phase 210729
16Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 213168
17Anti-Inflammatory Agents, Non-SteroidalPhase 1, Phase 24443
18Antirheumatic AgentsPhase 1, Phase 210956
19HormonesPhase 1, Phase 214415
20Hormone AntagonistsPhase 1, Phase 213180
21Gastrointestinal AgentsPhase 1, Phase 28402
22Insulin, Long-ActingPhase 2362
23Insulin degludec, insulin aspart drug combinationPhase 2248
24Insulin, Globin ZincPhase 24645
25insulinPhase 24646
26
Pancrelipaseapproved97053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
27
Palmitic Acidexperimental2257-10-3985
Synonyms:
1-Hexyldecanoate
1-Hexyldecanoic Acid
1-Hexyldecanoic acid
1-Pentadecanecarboxylic acid
C16 fatty acid
Cetylic acid
Edenor C16
Emersol 140
Emersol 143
FAT
Glycon P-45
Hexadecanoate
Hexadecanoate (n-C16:0)
Hexadecanoic acid
Hexadecanoic acid palmitic acid
Hexadecoate
Hexadecoic acid
Hexadecylic acid
Hexaectylic acid
Hydrofol
Hydrofol acid 1690
Hystrene 8016
Hystrene 9016
 
Industrene 4516
Kortacid 1698
Loxiol EP 278
Lunac P 95
Lunac P 95KC
Lunac P 98
N-Hexadecanoate
N-Hexadecanoic acid
N-Hexadecoate
N-Hexadecoic acid
PAM
PLM
Palmitate
Palmitic acid
Palmitinate
Palmitinic acid
Palmitinsaeure
Palmitoate
Palmitoic acid
Pentadecanecarboxylate
Pentadecanecarboxylic acid
Prifac 2960
Prifrac 2960
Pristerene 4934
Univol U332
28glucagon478
29Glucagon-Like Peptide 1715
30pancreatin970

Interventional clinical trials:

idNameStatusNCT IDPhase
1Using Glucose Sensors to Prevent HypoglycemiaCompletedNCT00554281Phase 3
2Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free ImmunosuppressionUnknown statusNCT00566813Phase 1, Phase 2
3Cardiac Surgery Neuroprotection Study in EldersCompletedNCT01561378Phase 2
4Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free ImmunosuppressionActive, not recruitingNCT00306098Phase 2
5Intracellular Counter-regulatory Mechanisms Following Low Blood GlucoseCompletedNCT01919788
6GLP-1 Analogs for Neuroprotection After Cardiac ArrestCompletedNCT02442791
7Exercise Physiology StudyRecruitingNCT03090451
8Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose DataActive, not recruitingNCT03028220
9Sub-Cutaneous Insulin in Hyperglycaemic EmergenciesWithdrawnNCT00467246

Search NIH Clinical Center for Hypoglycemic Coma

Genetic Tests for Hypoglycemic Coma

About this section

Genetic tests related to Hypoglycemic Coma:

id Genetic test Affiliating Genes
1 Hypoglycemic Coma27

Anatomical Context for Hypoglycemic Coma

About this section

MalaCards organs/tissues related to Hypoglycemic Coma:

36
Brain, Liver, Temporal lobe, Endothelial, Breast, Eye, Heart

Publications for Hypoglycemic Coma

About this section

Articles related to Hypoglycemic Coma:

(show top 50)    (show all 106)
idTitleAuthorsYear
1
Smartwatch's Application Algorithm to Prevent Sudden Death and Brain Damage in Hypoglycemic Coma. (26659660)
2015
2
Roving eye movements in a patient with hypoglycemic coma. (25984318)
2015
3
Reversible corona radiata diffusion restriction in hypoglycemic coma. (25553230)
2015
4
Regional Assessment of Severe Hypoglycemic Coma Events in Finland. (27200578)
2014
5
Hypoglycemic coma due to insulin autoimmune syndrome induced by methimazole: A rare case report. (25289063)
2014
6
Recurrent Hypoglycemic Coma as the Initial and Single Clinical Manifestation of Advanced Hepatocellular Carcinoma. (25407746)
2014
7
A case of hypoglycemic coma with good outcome despite sustained unconsciousness and widespread leukoencephalopathy. (24097322)
2013
8
Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study. (24150837)
2013
9
Decreased vascular endothelial growth factor response to acute hypoglycemia in type 2 diabetic patients with hypoglycemic coma. (22209065)
2012
10
Silent myocardial infarction during hypoglycemic coma. (22276266)
2012
11
Effects of d-3-hydroxybutyrate treatment on hypoglycemic coma in rat pups. (21056562)
2011
12
Catecholamine-resistant shock and hypoglycemic coma after cardiotomy in a patient with unexpected isolated ACTH deficiency. (21400210)
2011
13
Protective effects of d-3-hydroxybutyrate and propionate during hypoglycemic coma: clinical and biochemical insights from infant rats. (21439874)
2011
14
Bilateral posterior shoulder dislocation with defect secondary to hypoglycemic coma. (21246228)
2011
15
Hypoglycemic coma in a patient with anorexia nervosa coincident with acute exacerbation of liver injury induced by oral intake of nutrients. (20686290)
2010
16
Elderly case of prolonged hypoglycemic coma presenting with reversible magnetic resonance imaging changes. (20887629)
2010
17
The influence of hypoglycemia on cerebral blood flow in cases of hypoglycemic coma. (19305083)
2009
18
Another dangerous combination for hypoglycemic coma: concurrent use of sibutramine and lorazepam. (18202087)
2008
19
Teaching NeuroImage: hippocampal involvement in a patient with hypoglycemic coma. (19001244)
2008
20
Truncation of the krebs cycle during hypoglycemic coma. (18673151)
2008
21
Hypoglycemic coma secondary to big insulin-like growth factor II secretion by a giant phyllodes tumor of the breast. (17319862)
2007
22
The evolution of a pleural nodule into a giant fibrous tumor associated with hypoglycemic coma. (17317199)
2007
23
Bilateral basal ganglia lesions after hypoglycemic coma in a 6-year-old child. (17621490)
2007
24
Extensive white matter injury in hypoglycemic coma. (17389314)
2007
25
Malignant solitary fibrous tumor of the thigh accompanied by hypoglycemic coma. A case report. (16080476)
2005
26
Magnetic resonance imaging and diffusion-weighted imaging changes after hypoglycemic coma. (15746233)
2005
27
Unexpected recovery from prolonged hypoglycemic coma: a protective role of metformin? (15678315)
2005
28
Hypoglycemic coma revealing a solitary fibrous tumor of the pleura]. (16292188)
2005
29
Severe hypoglycemic coma due to insulin autoimmune syndrome. (15759820)
2005
30
Central pontine myelinolysis associated with a hypoglycemic coma in anorexia nervosa. (16168799)
2005
31
Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma. (15277649)
2004
32
Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma. (14745290)
2004
33
Solitary fibrous tumor of the liver with presenting symptoms of hypoglycemic coma. (15098777)
2004
34
Hypoglycemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements. (15333503)
2004
35
Sulfonylurea-induced prolonged hypoglycemic coma: experience with dexamethasone. (12974447)
2003
36
Reversible hypoglycemic coma despite bilateral absence of the median nerve N20 evoked potential. (12771284)
2003
37
Olanzapine and hypoglycemic coma in a frail elderly woman. A case report. (12971357)
2003
38
Bispectral index monitoring during hypoglycemic coma. (12088817)
2002
39
Diffusion-weighted MR in hypoglycemic coma. (11552039)
2001
40
Protein ubiquitination in rat brain following hypoglycemic coma. (11165431)
2001
41
MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets. (11412899)
2001
42
Response to training in blood glucose awareness is related to absence of previous hypoglycemic coma. (10937524)
2000
43
Normal pressure hydrocephalus in diabetic patients with recurrent episodes of hypoglycemic coma. (10670909)
2000
44
Differential phosphorylation at Ser473 and Thr308 of Akt-1 in rat brain following hypoglycemic coma. (10973608)
2000
45
Is neuronal injury caused by hypoglycemic coma of the necrotic or apoptotic type? (10905628)
2000
46
Adrenal crisis presenting as hypoglycemic coma. (10663290)
2000
47
Alteration of cyclic adenosine monophosphate response element binding protein in rat brain after hypoglycemic coma. (11083229)
2000
48
Brain O2 consumption and glutamate release during hypoglycemic coma in piglets are temperature sensitive. (10362687)
1999
49
Hypoglycemic coma masquerading thyrotoxic storm. (10563748)
1999
50
Drug-induced hypoglycemic coma in 102 diabetic patients. (9989540)
1999

Variations for Hypoglycemic Coma

About this section

Expression for genes affiliated with Hypoglycemic Coma

About this section
Search GEO for disease gene expression data for Hypoglycemic Coma.

Pathways for genes affiliated with Hypoglycemic Coma

About this section

GO Terms for genes affiliated with Hypoglycemic Coma

About this section

Cellular components related to Hypoglycemic Coma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.5IGF2, VEGFA
2extracellular spaceGO:00056159.0HBA2, IGF2, INS, VEGFA
3extracellular regionGO:00055768.4HBA2, IGF2, INS, NTF3, VEGFA

Biological processes related to Hypoglycemic Coma according to GeneCards Suite gene sharing:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1glucose metabolic processGO:000600610.3IGF2, INS
2insulin receptor signaling pathwayGO:000828610.3IGF2, INS
3positive regulation of glycogen biosynthetic processGO:004572510.3IGF2, INS
4positive regulation of insulin receptor signaling pathwayGO:004662810.3IGF2, INS
5positive regulation of MAPK cascadeGO:004341010.2IGF2, INS
6positive regulation of mitotic nuclear divisionGO:004584010.2IGF2, INS
7positive regulation of cell divisionGO:005178110.2IGF2, VEGFA
8positive regulation of protein autophosphorylationGO:003195410.1INS, VEGFA
9positive regulation of protein kinase B signalingGO:005189710.1IGF2, INS
10activation of protein kinase B activityGO:003214810.0INS, NTF3
11positive regulation of receptor activityGO:20002739.9IGF2, VEGFA
12induction of positive chemotaxisGO:00509309.8NTF3, VEGFA
13positive chemotaxisGO:00509189.8NTF3, VEGFA
14positive regulation of peptidyl-serine phosphorylationGO:00331389.7NTF3, VEGFA
15positive regulation of cell migrationGO:00303359.4INS, NTF3, VEGFA
16positive regulation of receptor internalizationGO:00020929.1NTF3, VEGFA
17positive regulation of cell proliferationGO:00082848.9IGF2, INS, NTF3, VEGFA
18positive regulation of peptidyl-tyrosine phosphorylationGO:00507318.8IGF2, INS, NTF3, VEGFA

Molecular functions related to Hypoglycemic Coma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1hormone activityGO:000517910.1IGF2, INS
2insulin receptor bindingGO:00051589.9IGF2, INS
3chemoattractant activityGO:00420569.8NTF3, VEGFA
4insulin-like growth factor receptor bindingGO:00051599.6IGF2, INS
5growth factor activityGO:00080839.2IGF2, NTF3, VEGFA

Sources for Hypoglycemic Coma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet